Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Famotidine tested in schizophrenic patients

Aug. 30, 1996

DuPont Merck reports on CRH antagonists for anxiety, depression

Aug. 30, 1996

Russian investigators describe new tranquilizer

Aug. 30, 1996

BMS, Sano to collaborate on transdermal BuSpar development

Aug. 30, 1996

Flunitrazepam may alter circadian sleep-wake rhythms

Aug. 30, 1996

Merck & Co. reports NK1 antagonists

Aug. 30, 1996

Lidocaine topical patch effective in treating post-herpetic neuralgia

Aug. 30, 1996

Potential tachykinin NK1 antagonists from Merck & Co.

Aug. 23, 1996

Further nitric oxide synthase inhibitors from Chugai

Aug. 23, 1996

The Wellcome Foundation claims nitric oxide synthase inhibitors

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...